Skip to main content

Sleeping Well with Parkinson's

December 20, 2018

This month, we replay a popular webinar on sleep disturbances -- a common non-motor symptom of Parkinson's disease that may cause difficulty falling or staying asleep. Our panelists discuss how to manage these disturbances and current research on sleep and PD.

Webinar Details


Thursday, December 20, 2018


1 hr


12:00 pm ET
  • MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: May 18, 2017
    Re-reviewed for Re-release: December 20, 2018
    Date CME Credit No Longer Available: December 20, 2020

    Learning Objectives
    • Describe sleep disorders that are commonly associated with Parkinson's disease. 
    • Discuss Parkinson's motor and non-motor symptoms as well as medications that can affect sleep. 
    • Summarize pharmacological and non-pharmacological treatments for sleep disturbances in Parkinson's. 
    • Recognize ongoing research in sleep and Parkinson's disease.
    Target Audience

    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing, LLC designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.


    Dave Iverson
    Nothing to disclose

    Carlos Singer, MD
    Professor of Neurology, and Director of the Divison of Parkinson's Disease and Movement Disorders
    University of Miami
    Nothing to disclose

    Aleksandar Videnovic, MD 
    Associate Professor of Neurology, Harvard Medical School
    Director, Program on Sleep, Circadin Biology and Neurodegeneration, Massachusetts General Hospital
    Research-Grants: Pfizer, Sunovion, NIH, Adamas, National Parkinson Foundation, Parkinson Study Group, Lundbeck
    Advisory Role: Neurocrine
    Honoraria: Neurocrine, US World Meds, TEVA

    Michael Sweet, Sr.
    Policy and Advocacy Volunteer, The Michael J. Fox Foundation
    Nothing to disclose

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.